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Approximately 10% to 14% of all ischemic strokes occur in young adults (aged 18–50 years).1–7 The incidence of 
stroke in young adults is rising, which is a major concern.8
Their outcome is usually considered fairly good because 
these patients usually have a good motor recovery,9,10 and 
outcome after stroke is usually assessed with rating scales 
that predominantly measure motor performance.11 However, 
poststroke outcome is also very much dependent on cogni-
tive performance after stroke. Surprisingly, there are only a 
few studies that addressed cognitive outcome on the short 
term (4–12 months)12,13 and none on the long term. Although 
these short-term studies found somewhat lower cognitive 
performance in patients with ischemic stroke compared with 
controls, that may still very well be compatible with the com-
mon observation of gradual cognitive recovery, which may 
continue for ≥1 year after stroke.14,15
Because life expectancy of most of these patients exceeds by 
far 1 year,16 patients need to be informed about their cognitive 
prognosis, not only on the short term, but also particularly for 
the coming decades, as they are in a period of life in which 
they start forming a family, have an active social life, and make 
decisive career moves. It is exactly this long-term perspective 
that is currently missing. The aim of the present study was to 
investigate the long-term cognitive performance after a first-
ever young ischemic stroke.
Patients and Methods
Study Design
This study is part of the Follow-Up of Transient ischemic 
attack and stroke patients and Unelucidated Risk factor 
Evaluation (FUTURE) study a large cohort study which inves-
tigates causes and consequences of stroke in young adults.17 
The Medical Review Ethics Committee region Arnhem-
Nijmegen approved the study and the recruitment of controls.
The present study comprises all consecutive patients with 
a first-ever ischemic stroke of presumed arterial origin, aged 
18 to 50 years, admitted to Radboud University Nijmegen 
Medical Center from January 1, 1980, to November 1, 2010. 
This hospital is a large academic center, receiving patients 
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from both the direct environment and serving as a tertiary 
referral center. Our hospital is the only academic medical cen-
ter in our region.
Patients were identified through a prospective registry of 
all consecutive young ischemic stroke patients that has been 
kept at the department since the 1970s with a standardized 
collection of baseline, clinical characteristics, and neurologi-
cal examination. Ischemic stroke was defined as focal neuro-
logical deficit persisting >24 hours. The diagnosis of ischemic 
stroke and lesion location was based on medical records and 
radiological findings.
The diagnostic techniques have been improved during a 
30-year period and to minimize bias, all initial diagnoses were 
reviewed by a panel of 2 experts from a pool of 4 (F.-E.d.L., 
E.J.v.D., R.M.A., L.J.D.) and in cases of disagreement, a con-
sensus meeting was held to adjudicate the event.
Primary exclusion criteria for patients with ischemic stroke 
in the FUTURE study were cerebral venous sinus thrombosis 
and retinal infarction. There were additional exclusion crite-
ria for cognitive assessment on the basis of the neurological 
examination, which was also a part of the FUTURE study 
(Figure 1).
Controls were recruited among patients’ spouses, relatives, 
or social environment. They had to be aged ≥18 years without 
a history of transient ischemic attack or stroke. The control 
group and patient group were matched for age, sex, and level 
of education. Controls were all living independently, none 
fulfilled the clinical criteria of dementia. They were recruited 
from the same environment as patients.
Written informed consent was obtained from all participants.
Cognitive Assessment
Neuropsychological tests were administered between Novem-
ber 2009 and the end of 2011. They covered the main cognitive 
domains and these tests have been previously applied in large-
scale epidemiological studies in cerebrovascular disease.18,19 
Strict instruction protocols were used to assess cognitive per-
formance and researchers were trained. The following cognitive 
domains were examined: processing speed (the written admin-
istration of the Symbol-Digit Modalities Test, Abbreviated 
Stroop Color Word Test, parts I and II), visuoconstruction 
(Rey–Osterrieth Complex Figure—copy trial), working 
memory (Paper and Pencil Memory Scanning Test), immedi-
ate memory (Rey–Osterrieth Complex Figure—immediate 
recall and the total number of words immediately recalled 
in the 3-trial version of the Rey Auditory Verbal Learning 
Test), delayed memory (delayed recall on the Rey–Osterrieth 
Complex Figure and the Rey Auditory Verbal Learning Test), 
attention (Verbal Series Attention Test), and executive function-
ing (Verbal Fluency and Stroop Interference). To account for 
speed-accuracy trade-off on the Stroop test, Paper and Pencil 
Memory Scanning Test, and Verbal Series Attention Test, com-
posite scores were calculated [accuracy(%)/reaction time].20 
Stroop Interference was computed by dividing the composite 
Stroop part III score by the mean of the composite scores of 
parts I and II. To prevent potential bias in scoring the Rey–
Osterrieth Complex Figure, 2 researchers independently rated 
10% of the complex figures in both patients and controls, with 
high inter-rater reliability using the Spearman correlation coef-
ficients (Copy: r
s
=0.90; Immediate recall: r
s
=0.97; Delayed 
recall: r
s
=0.95). Detailed information on the neuropsychologi-
cal examination is described extensively elsewhere.17
Other Measurements
Age, sex, level of education, depressive symptoms, and 
fatigue were considered possible confounders. Level of edu-
cation was scored with a Dutch scoring system (1=less than 
primary school; 7=university degree).21
Baseline first-ever ischemic
stroke population
n = 606
Follow-up study population
n = 543
Lost to follow-up: n = 63
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Refused to participate in the FUTURE study: n = 96
Follow-up cognitive
assessment in first-ever
ischemic stroke patients
n = 277
Exclusion cognitive assessment:
1. Severely disabled patients based on the
neurological exam: n = 6*
2. Participated in the FUTURE study, but refused
to visit the research center: n = 42
Deceased: n = 122
Follow-up survivors
n = 325
Figure 1. Flowchart of the study population. 
*Severe psychiatric disorder (1), inability to 
communicate in Dutch (1), blind and deaf (1), 
severe fatigue (1), severe aphasia (only sounds) 
and bilateral hemianopia (1), severe physical 
disabilities (1). FUTURE indicates Follow-Up of 
Transient Ischemic Attack and Stroke Patients 
and Unelucidated Risk factor Evaluation.
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Table 1. Demographic and Clinical Characteristics of the Study Population and Patients With Ischemic Stroke Who Refused 
Cognitive Assessment
Participants With Ischemic Stroke (n=277) Refusals† (n=138) P Value‡ Controls (n=146)
Age at index event, y 40.0 (7.7) 40.1 (8.0) 0.84§ NA
Men (%) 123 (44.4) 59 (42.8) 0.75|| 61 (41.8)
Follow-up duration 11.0 (8.2) NA … NA
 <10 y (%) 144 (51.9) NA … NA
 ≥10 y (%) 133 (48.0) NA … NA
Lesion location
 Supratentorial stroke (%) 218 (79.0) NA … NA
  Left (%) 116 (42.0) NA … NA
  Right (%) 102 (37.0) NA … NA
  Bilateral (%) 7 (2.5) NA … NA
 Infratentorial stroke (%) 51 (18.5) NA … NA
Age at follow-up examination 50.9 (10.3) NA … 48.6 (11.7)
Education 5 (4–6) NA … 5 (5–6)
NIHSS score at admission 4 (2–8) 4 (2–7.75) 0.79# NA
Barthel Index at follow-up 96.9 (9.7) NA … 99.6 (1.5)
 Good outcome (BI, ≥85) (%) 262 (94.6) NA … 146 (100)
Modified Ranking Scale at follow-up 1 (1–2) NA … 0 (0-0)
 Good outcome (mRS, 0–1) (%) 191 (69.0) NA … 139 (95.2)
Marital status at follow-up
 Married (%) 180 (65.7) NA … 97 (66.4)
 Widowed (%) 5 (1.8) NA … 4 (2.7)
 Divorced (%) 22 (8.0) NA … 6 (4.1)
 Never married (%) 67 (24.5) NA … 39 (26.7)
Employment status at follow-up*
 Working (%) 120 (51.9) NA … 101 (70.1.2)
 Unemployed (%) 94 (40.7) NA … 35 (24.3)
 Retired (%) 17 (7.4) NA … 8 (5.6)
MMSE at follow-up 26.3 (2.6) NA … 27.2 (1.9)
HADS—depressive symptoms 4.0 (3.6) NA … 2.5 (2.7)
CIS-20R—fatigue severity 30.3 (13.9) NA … 22.5 (12.8)
TOAST 0.21||
 Large-artery atherosclerosis (%) 66 (23.8) 42 (30.4) … NA
 Cardiac source of embolism (%) 26 (9.4) 10 (7.25) … NA
 Small-vessel occlusion (lacune) (%) 38 (13.7) 16 (11.6) … NA
 Stroke of other determined pathogenesis (%) 47 (17.0) 33 (23.9) … NA
 Multiple pathogenesis (%) 7 (2.5) 3 (2.2) … NA
 Stroke of undetermined pathogenesis (%) 93 (33.6) 24 (24.6) … NA
Vascular medical history
 Myocardial infarction (%) 16 (5.8) NA … 3 (2.1)
 Recurrent stroke (%) 30 (10.8) NA … NA
Vascular risk factors
 Hypertension (%) 150 (54.2) NA … 44 (30.1)
 Diabetes mellitus (%) 34 (12.3) NA … 6 (4.1)
 Dyslipidemia (%) 185 (66.8) NA … 26 (17.8)
 BMI at follow-up (%) 26.9 (5.1) NA … 26.9 (4.7)
(Continued)
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Table 1. (Continued)
Participants With Ischemic Stroke (n=277) Refusals† (n=138) P Value‡ Controls (n=146)
Smoking
 Current (%) 78 (28.2) NA … 38 (26.0)
 Ex-smoker (%) 129 (46.6) NA … 55 (37.7)
 Never (%) 70 (25.3) NA … 53 (36.3)
Alcohol (>2 U/d) (%) 19 (6.9) NA … 14 (9.6)
Data are expressed as mean (SD), number (%), or median (Q1–Q3). Missing data in participants with ischemic stroke: lesion location=0.4%, education=1.1%, NIHSS 
at admission=0.7%, marital status=1.1%; employment status: 2.5%, MMSE=2.9%, HADS depression=1.1%, CIS-20R=1.1%, BMI=3.2%, alcohol=0.4%. Missing data 
in the control group: employment status=1.4%, BMI=1.4%. Missing data in the refusals: NIHSS at admission=1.4%. 
BI indicates Barthel Index; CIS-20R, Checklist Individual Strength; HADS, Hospital Anxiety and Depression Scale; MMSE, Mini-Mental State Examination; mRS, 
modified Ranking Scale; NA, not applicable; NIHSS, National Institutes of Health Stroke Scale; and TOAST, Trial of Org 10172 in Acute Stroke Treatment.
*The proportion of patients with ischemic stroke with baseline employment (n=231) and who were unemployed, still employed, or retired at follow-up. Controls: 
employment status at follow-up.
†Patients with ischemic stroke who refused to participate in the FUTURE study (n=96)+ patients who participated in the FUTURE study, but refused to visit the 
research center (n=42).
‡Comparisons between participants with ischemic stroke and those who refused cognitive assessment.
§Student t test.
||Pearson χ2 test.
#Mann–Whitney U test.
Depressive symptoms were assessed using the Hospital 
Anxiety and Depression Scale,22 and fatigue was assessed 
using the subscale Subjective Fatigue of the revised Checklist 
Individual Strength (CIS-20R).23,24
Marital status (married, divorced, widowed, and never mar-
ried) at follow-up was reported. Employment status at follow-
up was defined as the number of patients who worked/studied 
at the time of their event and were unemployed, still employed, 
or retired at follow-up assessment. Employment status of con-
trols was defined as employed, unemployed, and retired at fol-
low-up assessment. Functional outcome during follow-up visit 
was evaluated using the Barthel Index25 and modified Ranking 
Scale.11 A good functional outcome was defined as an modified 
Ranking Scale score of 0 to 1 and a Barthel Index of ≥85.26
Furthermore, assessment of both the pathogenesis (Trial of 
Org 10172 in Acute Stroke Treatment)27 and severity (National 
Institutes of Health Stroke Scale)28 was performed retrospec-
tively in all cases using a validated approach29,30 because these 
scales did not exist at the time when a substantial proportion 
of the patients experienced their qualifying event.
We assessed vascular risk factors (hypertension, diabetes 
mellitus, dyslipidemia, smoking [current/former/never], cur-
rent alcohol use [>2 U/d]) and vascular disease (myocardial 
infarction and recurrent stroke) on the basis of medical history 
using a standardized, structured questionnaire, and the use of 
medication. Whenever a myocardial infarction or recurrent 
stroke was suspected, information retrieved was verified and 
adjudicated by physicians. The body mass index at follow-up 
was calculated as weight (kg) divided by height (m) squared.
Statistical Analysis
Baseline characteristics were presented as means (±SD), 
median (Q1–Q3), or number of cases (%). All statistical 
analyses were performed with IBM SPSS Statistics for 
Windows version 20.0 (IBM Corp., Armonk, NY). Baseline 
characteristics in young participants with ischemic stroke and 
patients with ischemic stroke who refused cognitive assessment 
were compared using a Pearson χ2 test, Mann–Whitney U 
test, or Student t test when appropriate. To adjust for multiple 
comparisons in all analyses a Bonferroni correction was 
applied (P values <0.0071 were considered significant because 
there were 7 pairwise comparisons for each analysis).
The mean raw cognitive test scores (±SD) for each test were 
calculated. The Rey Complex Figure—Copy trial showed a left 
skewed distribution; therefore, this variable was transformed 
(e5) to obtain a normal distribution to use in all subsequent 
analyses.31 For the purpose of data reduction, across-domain 
comparison, and statistical considerations, raw test scores 
were converted to Z scores, using the mean and SD of the con-
trols. Z scores of tests assigned to the same cognitive domain 
were averaged and were used in all subsequent analyses as 
composite Z score or domain score. If 1 test of a particular 
domain was missing, the domain score was occasionally based 
on the remaining tests of that domain (always<5.1%).
A 1-way ANCOVA model was used for each cognitive 
domain with a 2-level factor adjusting for age, sex, level of 
education, depressive symptoms, and fatigue severity. All 
P values reported were 2-sided and confidence intervals were 
calculated at the 95% confidence interval.
Linear regression was used to explore the effect of differences 
in follow-up duration and performance on cognitive domains 
adjusting for age, sex, level of education, depressive symptoms, 
and fatigue. Results were reported as standardized β coefficients.
Below Average Performance and Cognitive 
Impairment
Because of the long-term follow-up, patients differed in age at 
follow-up cognitive assessment. Obviously, age has an influ-
ence on cognitive performance apart from stroke.32 To account 
for differences in age, age-adjusted Z scores for each neuro-
psychological test were calculated using the mean and SD of 
the controls in 3 different strata of age at follow-up: 20 to 40, 
40 to 60, and 60 to 80 years. Next, Z scores of cognitive tests 
assigned to the same cognitive domain were averaged.
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The frequency of a below average performance (>1.0 SD 
below age-adjusted mean of controls) and cognitive impair-
ment (>1.5 SD) was determined.33
A Pearson χ2 test (or Fisher exact test when an expected 
cell count was <5) was used to investigate differences between 
patients and controls in the proportion of participants with 
cognitive impairment.
Lesion Location and Cognitive Outcome
The frequency of cognitive impairment or a below average 
performance for each cognitive domain in patients with supra-
tentorial infarction (left versus right) and infratentorial infarc-
tion was determined. The proportion of patients with cognitive 
impairments were compared with controls using a Pearson χ2 
test (or Fisher exact test when an expected cell count was <5).
Recurrent Stroke
All above described analyses were conducted including 
and excluding patients with a recurrent stroke to investigate 
whether patients with recurrent events influenced the results.
Results
The study population consisted of 277 participants 
with ischemic stroke and 146 controls (Figure 1). Basic 
demographic and clinical characteristics of the study 
population are described in Table 1 and neuropsychological 
test scores are presented in Table 2. Mean age of patients was 
40.0 years (SD 7.7) at stroke onset; 55.6% was women. Mean 
follow-up of the study population was 11.0 years (SD 8.2), 
whereas 48.0% had a follow-up of ≥10 years. Participants did 
not significantly differ on basic demographical and clinical 
characteristics from patients with ischemic stroke who refused 
to participate or who did participate in the FUTURE study but 
did not want to visit the research center (Table 1).
Patients with ischemic stroke had a worse cognitive perfor-
mance on 6 cognitive domains after a mean follow-up of 11 years 
compared with controls (processing speed: F(1,406)=35.4, 
P<0.0001; working memory: F(1,407)=41.7, P<0.0001; 
immediate memory: F(1,412)=14.0, P=0.0002; delayed 
memory: F(1,408)=17.7, P<0.0001; attention: F(1,396)=28.6, 
P<0.0001; executive functioning: F(1,409)=17.2, P<0.0001 
(Figure 2).
Follow-up Duration
In patients with ischemic stroke longer follow-up duration 
was associated with a lower immediate memory (β=−0.23; 
P=0.001), delayed memory (β=−0.30; P<0.0001), and execu-
tive functioning score (β=−0.22; P=0.004).
Below Average Performance and Cognitive 
Impairment
Patients with ischemic stroke showed a substantially higher 
proportion of patients with a below average performance (−1.5 
SD≤composite Z score<−1 SD) or cognitive impairment (>1.5 
SD) compared with controls (Figure 3A). Up to 50% of all 
patients with ischemic stroke had a below average performance 
or cognitive impairment. Cognitive impairments were frequent 
among patients, affecting ≤34.5%. Deficits in processing 
speed, working memory, and attention were most common.
Lesion Location and Cognitive Outcome
One patient could not be classified as supratentorial or 
infratentorial infarction (infarction in basal ganglia or brain 
stem). Seven patients with bilateral supratentorial infarc-
tion were excluded from the analysis because the number of 
patients was too small for further analyses. The results showed 
that patients with a left supratentorial infarction had the worst 
cognitive outcome, ≤45.5% of patients had cognitive impair-
ments on the long term (Figure 3B).
Recurrent Stroke
After exclusion of patients with a recurrent stroke (n=30), 
there was no longer a significant negative relation between 
follow-up duration and executive functioning score in patients 
with ischemic stroke.
Discussion
This study showed that a substantial proportion of young 
patients with ischemic stroke after a mean follow-up of 11 
Table 2. Neuropsychological Test Scores of Patients With a 
Previous Young Stroke and Controls
Cognitive Domain and Test Ischemic Stroke Controls
Processing speed
 SDMT 42.6 (13.7) 53.3 (10.2)
 Stroop part I* 4.0 (1.1) 4.7 (0.8)
 Stroop part II* 3.2 (0.9) 3.7 (0.6)
Visuoconstruction
 ROCF copy 30.7 (5.4) 32.4 (2.8)
Memory
 Working memory
  PPMST %* 2.8 (1.0) 3.6 (0.8)
  PPMST S* 2.4 (0.8) 3.1 (0.7)
  PPMST MP* 1.6 (0.5) 2.0 (0.5)
  PPMST DHN* 1.3 (0.4) 1.6 (0.4)
 Immediate memory
  RAVLT trial 1–3 18.3 (6.3) 22.1 (6.1)
  ROCF immediate recall 16.4 (6.5) 18.3 (5.8)
 Delayed memory
  RAVLT delayed recall 5.3 (2.8) 6.9 (2.8)
  ROCF delayed recall 15.8 (6.3) 18.0 (5.7)
Attention
 Total score of the VSAT* 1.2 (0.5) 1.5 (0.4)
Executive functioning
 Verbal fluency 21.3 (6.8) 24.4 (5.8)
 Interference* 0.51 (0.1) 0.56 (0.1)
Data are expressed as mean (SD). PPMST indicates Paper and Pencil Memory 
Scanning Test; RAVLT, Rey Auditory Verbal Learning Test; ROCF, Rey–Osterrieth 
Complex Figure; SDMT, Symbol-Digit Modalities Test; and VSAT, Verbal Series 
Attention Test.
*Speed-accuracy composite score. Higher scores indicate better performance 
on all measures.
S, MP, DHN: Patients had to memorize the letters S, MP, and DHN and find 
them among 120 distracting letters.
 by guest on May 23, 2016http://stroke.ahajournals.org/Downloaded from 
1626  Stroke  June 2013
years showed a worse cognitive performance on a wide range 
of cognitive domains compared with a matched stroke-free 
population. Patients with a left surpratentorial infarction had 
the worst cognitive outcome.
Strong elements of our study include a large sample size in 
a single center, with a high response rate.12,13 We used exten-
sive neuropsychological testing rather than a short cognitive 
screen, and we included a representative control group as a 
reference for neuropsychological examination.
However, some methodological issues need to be addressed. 
First, the study was not community based, but hospital based 
and, therefore, our sample may not represent all young stroke 
survivors in our catchment area. However, we think that our 
population with stroke is representative to the wider Dutch 
population with stroke. Those who survive usually visit a 
university medical center during the course of their disease. 
Furthermore, the age and sex standardized prevalence of 
stroke in our region equals that of the age and sex standard-
ized prevalence of stroke in the Netherlands.34 We, therefore, 
think that our cohort has a good external validity. This is also 
underlined by the fact that we included all consecutive cases 
admitted to our hospital.
Second, cognitive data of patients who refused to partici-
pate obviously were lacking, but their baseline characteristics 
did not differ from participants in the present study, making a 
selection bias unlikely.
Although we investigated a wide range of cognitive domains, 
agnosia or language comprehension12 were not included in our 
neuropsychological assessment. On the basis of the neurologi-
cal examination, we considered the proportion of patients with 
these symptoms to be small and, therefore, we think that this 
has not largely influenced cognitive performance.
We found relatively low MMSE scores in both the patients 
and the controls, compared with others12 and healthy older 
adults.35 However, all controls lived independently and none 
fulfilled the clinical criteria for dementia. Furthermore, 
the diagnostic accuracy of the MMSE in detecting cogni-
tive impairment is generally poor, especially outside the 
Alzheimer domain36; hence, we think this finding is of little 
clinical relevance.
Longer follow-up, adjusted for age effects, was associ-
ated with a decrease in cognitive functioning in patients with 
ischemic stroke. Longer time interval might be associated 
with incident comorbidity that could in turn have negatively 
affected cognitive performance. Another explanation is that 
these patients are older and that, apart from the stroke, neu-
rodegenerative pathology might have emerged that interacts 
with the cerebrovascular disease.37 A better understanding of 
this interaction is important as especially those with the lon-
gest follow-up are the oldest patients who might be at risk for 
further cognitive decline, because of this interaction of vascu-
lar lesions and neurodegenerative pathology.
Two studies have investigated cognitive performance in 
2413 and 4012 young patients with ischemic stroke 4 to 12 
months after stroke. Malm et al13 examined 24 patients with 
cerebellar infarcts and cognitive domains most affected were 
mental speed, cognitive flexibility, and working memory. We 
also found that an infratentorial infarction was associated 
with impairments in processing speed and working memory. 
Cao et al12 investigated 40 young patients with ischemic 
stroke and assessed other domains and found that language 
comprehension, reasoning, and verbal memory to be most 
affected. Processing speed was not assessed in these patients.12 
Comparing our results with these 2 studies, we found similar 
deficits not only in verbal memory, working memory, and pro-
cessing speed, but also in executive functioning and attention 
are common on the long term in patients with ischemic stroke. 
These 2 domains were not addressed in reported studies.12,13
A substantial proportion ≤50% of young patients with 
ischemic stroke had below average cognitive performance or 
Figure 2. Cognitive performance ≈11 years after first-ever ischemic stroke in young adults compared with controls. Adjusted mean com-
posite Z score (95% confidence interval [CI]) per cognitive domain (adjusted for age, sex, education, depressive symptoms, and fatigue). 
Gray band represents the 95% CI of the adjusted mean composite Z score of controls. Missing values in different domains: 0.7% to 
6.5%. No missing values in the control group. *Significant difference between patients with ischemic stroke and controls. P value <0.0071 
was considered significant.
 by guest on May 23, 2016http://stroke.ahajournals.org/Downloaded from 
Schaapsmeerders et al  Impaired Cognition After Stroke in Young Adults  1627
impairment, despite the fact that the median of initial stroke 
severity was relatively mild. This highlights the influence 
of cerebrovascular lesions on cognitive performance, even 
decades after the stroke. It could also be that a severity rating 
scale, which includes predominantly motor signs (National 
Institutes of Health Stroke Scale), may underestimate the 
effect of stroke on other than motor symptoms. This would 
justify a basic careful neuropsychological examination of 
stroke patients in the (sub)acute phase of the disease.
Interestingly, a focal stroke on the long term seems to have 
a widespread impact on cognition, affecting multiple cogni-
tive domains. Increasing evidence suggests that focal lesions 
can have a widespread, diffuse impact on brain network 
organization,38 which may explain the cognitive impairments 
attributable to dysfunction of the brain, remote from the site 
of the infarction.39
The stroke in young adults seems to have a relatively better 
cognitive prognosis as compared with stroke in the elderly, as 
we found cognitive deficits in 20.4% to 34.8% of our young 
patients with ischemic stroke, whereas 31% to 77%40 was 
reported in elderly stroke survivors. This difference in cogni-
tive prognosis is perhaps because of a better collateral blood 
supply with an attendant lower volume of the infarction, a 
more pronounced neuronal plasticity, and the absence of neu-
rodegenerative pathology in younger adults.41
Conclusions
In young patients with ischemic stroke, with in general a good 
motor recovery, long-term cognitive impairments are common. 
Given the importance of cognitive performance for poststroke 
quality of life, cognitive functioning should be monitored in 
clinical practice. This may also yield valuable information for 
treating rehabilitation services and return to work.
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Figure 3. The proportion (%) of patients 
with ischemic stroke and controls with a 
below average performance (composite 
Z score >1.0 SD below the age-adjusted 
mean of controls) or a cognitive impair-
ment (>1.5 SD) ≈11 years after stroke 
(A). The relationship between lesion loca-
tion and the proportion of patients with a 
below average performance or a cognitive 
impairment compared with controls (B). 
Con indicates control group; Inf, infraten-
torial infarction; IS, ischemic stroke; LS, 
left supratentorial infarction; and RS, right 
supratentorial infarction. *Significantly 
higher proportion of patients with cognitive 
impairment compared with controls.  
P value <0.0071 was considered 
significant.
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